Patients' Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease: lessons learned from the German National Registry

J Eur Acad Dermatol Venereol
20 October 2023
https://pubmed.ncbi.nlm.nih.gov/37863661/

Background: Hailey-Hailey disease (HHD) remains a difficult-to-treat dermatosis and little is known about the patient's perception of the disease activity, the treatment success, and its impact on quality-of-life (QoL).

 

Linda Bluestein, MD - LDN Radio Show August 2023 (LDN; low dose naltrexone)

 

 

Linda Elsegood: Today we're joined by pharmacist Dr Dawn Ipsen who's the owner of two pharmacies in Washington state. Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist? 

 


Linda Elsegood: Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I'm your host Linda Elsegood. Today I'd like to welcome our guest Pharmacist Suzanne Rosenberg from Community Compounding Pharmacy in Oregon. 

So could you tell us what made you decide to become a pharmacist? 

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus

Case Reports; JAAD Case Rep
19 June 2023
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339115/

D

Today we're joined by pharmacist Dr Dawn Ipsen who's the owner of two pharmacies in Washington State, Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist? 

 

Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I'm your host Linda Elsegood. Today we're joined by Ray Solano from PD Labs. He's also a nutritionist. Could you tell us a bit of background about yourself?